Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Matrix Capital Management Company, LP

Q2 2023 · 13F-HR

Matrix Capital Management Company, LPholdings as filed

Filed 2023-08-14 · accession 0001172661-23-003194

$8.61B
Reported value
19
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
67066G104NVDANVIDIA CORPORATION$1.34B15.5%3,163,700CommonSOLE
G39387108GFSGLOBALFOUNDRIES INC$1.10B12.8%17,048,000CommonSOLE
038222105AMATAPPLIED MATLS INC$1.02B11.8%7,052,700CommonSOLE
893641100TDGTRANSDIGM GROUP INC$979.0M11.4%1,094,900CommonSOLE
023135106AMZNAMAZON COM INC$956.3M11.1%7,335,828CommonSOLE
021369103ALTREURALTAIR ENGR INC$847.5M9.85%11,174,200CommonSOLE
573874104MRVLMARVELL TECHNOLOGY INC$510.1M5.93%8,532,697CommonSOLE
98943L107ZNTLZENTALIS PHARMACEUTICALS INC$393.8M4.58%13,959,973CommonSOLE
N07059210ASMLASML HOLDING N V$360.3M4.19%497,200CommonSOLE
98138H101WDAYWORKDAY INC$358.3M4.16%1,586,043CommonSOLE
871607107SNPSSYNOPSYS INC$265.5M3.08%609,735CommonSOLE
747525103QCOMQUALCOMM INC$221.5M2.57%1,861,000CommonSOLE
00650F109ADPTADAPTIVE BIOTECHNOLOGIES COR$77.7M0.90%11,572,590CommonSOLE
05153U107AURAAURA BIOSCIENCES INC$66.2M0.77%5,362,870CommonSOLE
L7579L106PERIMETER SOLUTIONS SA$45.9M0.53%7,462,500CommonSOLE
00653A107ADAPYADAPTIMMUNE THERAPEUTICS PLC$36.1M0.42%38,974,185CommonSOLE
052769106ADSKAUTODESK INC$24.3M0.28%119,000CommonSOLE
92332V107VTYXUSDVENTYX BIOSCIENCES INC$2.9M0.03%89,900CommonSOLE
98980G102ZSZSCALER INC$2.7M0.03%18,405CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.